These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20042270)

  • 1. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?
    Stead LG; Jain A; Bellolio MF; Odufuye AO; Dhillon RK; Manivannan V; Gilmore RM; Rabinstein AA; Chandra R; Serrano LA; Yerragondu N; Palamari B; Decker WW
    Clin Neurol Neurosurg; 2010 May; 112(4):275-81. PubMed ID: 20042270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.
    Nicolini A; Ghirarduzzi A; Iorio A; Silingardi M; Malferrari G; Baldi G
    Haematologica; 2002 Sep; 87(9):948-56. PubMed ID: 12217807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcome in warfarin-related intracerebral hemorrhage.
    Zubkov AY; Mandrekar JN; Claassen DO; Manno EM; Wijdicks EF; Rabinstein AA
    Arch Neurol; 2008 Oct; 65(10):1320-5. PubMed ID: 18852345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage.
    Rizos T; Jenetzky E; Herweh C; Hug A; Hacke W; Steiner T; Veltkamp R
    Ann Neurol; 2010 Jun; 67(6):788-93. PubMed ID: 20517940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
    Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
    Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is the international normalised ratio a prognostic factor of mortality in intracerebral haemorrhage?].
    Sousa LD; Zorrilla JP; Latini MF; Alvarez Abut P; Ayala M; Romano LM; Gonorazky S; Ioli P; Ricci L
    Neurologia; 2011 Nov; 26(9):528-32. PubMed ID: 21414691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists.
    Alonso de Leciñana M; Huertas N; Egido JA; Muriel A; García A; Ruiz-Ares G; Díez-Tejedor E; Fuentes B
    Thromb Haemost; 2013 Dec; 110(6):1145-51. PubMed ID: 24030842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of non-variceal acute upper gastrointestinal bleeding in patients with antithrombotic therapy.
    Ortiz V; Ortuño J; Rodríguez-Soler M; Iborra M; Garrigues V; Ponce J
    Digestion; 2009; 80(2):89-94. PubMed ID: 19828953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the antithrombotic therapy at the time of intracerebral hemorrhage influence clinical outcome? analysis between the difference of antiplatelet and anticoagulant agents and clinical course.
    Okada T; Nakase T; Sasaki M; Ishikawa T
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1781-8. PubMed ID: 24957306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The necessity to assess anticoagulation status in elderly injured patients.
    Williams TM; Sadjadi J; Harken AH; Victorino GP
    J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal.
    Baggs JH; Patanwala AE; Williams EM; Erstad BL
    Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.
    Toyoda K; Yasaka M; Nagata K; Nagao T; Gotoh J; Sakamoto T; Uchiyama S; Minematsu K;
    Cerebrovasc Dis; 2009; 27(2):151-9. PubMed ID: 19039219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.
    Rosand J; Eckman MH; Knudsen KA; Singer DE; Greenberg SM
    Arch Intern Med; 2004 Apr; 164(8):880-4. PubMed ID: 15111374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage.
    Imberti D; Barillari G; Biasioli C; Bianchi M; Contino L; Duce R; D'Incà M; Mameli L; Pinna L; Ageno W
    Pathophysiol Haemost Thromb; 2008; 36(5):259-65. PubMed ID: 19996636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.